Proteomic analysis of gastric cancer and immunoblot validation of potential biomarkers

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 18, Issue 11

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Original Article

World J Gastroenterol. Mar 21, 2012; 18(11): 1216-1228
Published online Mar 21, 2012. doi: 10.3748/wjg.v18.i11.1216

Table 1 Patient and tumor characteristics

Characteristics	n (%)
Sex
Male	19 (59.4)
Female	13 (40.6)
Lauren’s classification
Intestinal	20 (62.5)
Diffuse	11 (34.4)
Mixed	1 (3.1)
Location
Corpus	8 (25)
Antrum	7 (21.9)
Cardia/gastroesophageal border	10 (31.2)
Several parts	7 (21.9)
Grade
Well-differentiated	2 (6.2)
Moderately differentiated	12 (37.5)
Poorly differentiated	12 (37.5)
Undifferentiated	6 (18.8)
pT
pT1b	1 (3.1)
pT2a	5 (15.6)
pT2b	15 (46.9)
pT3	11 (34.4)
pN
pN0	8 (25)
pN1	16 (50)
pN2	6 (18.8)
pN3	2 (6.2)

Citation: Kočevar N, Odreman F, Vindigni A, Grazio SF, Komel R. Proteomic analysis of gastric cancer and immunoblot validation of potential biomarkers. World J Gastroenterol 2012; 18(11): 1216-1228
URL: https://www.wjgnet.com/1007-9327/full/v18/i11/1216.htm
DOI: https://dx.doi.org/10.3748/wjg.v18.i11.1216

Kočevar N, Odreman F, Vindigni A, Grazio SF, Komel R. Proteomic analysis of gastric cancer and immunoblot validation of potential biomarkers. World J Gastroenterol 2012; 18(11): 1216-1228 [PMID: 22468085 DOI: 10.3748/wjg.v18.i11.1216]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.